<p>Alpha 1-Antitrypsin Deficiency (AATD) is a rare genetic disorder caused by mutations in the <i>SERPINA1</i> gene, which encodes the Alpha 1-Antitrypsin (AAT) protein. Individuals carrying pathogenic <i>SERPINA1</i> variants are predisposed to lung and liver damage. The most common AATD-associated <i>SERPINA1</i> alleles are the S and Z alleles, though additional variants have been identified. This study describes the discovery of a new <i>SERPINA1</i> variant detected in two unrelated families from two cities in southeastern France. This variant, named PiZ<sub>marseille</sub>, results from <i>in cis</i> combination of the PiZ allele and a rare variant known as PiZ<sub>bristol</sub>. PiZ<sub>marseille</sub> has been associated with early-onset liver disease in childhood. To further investigate this new variant, we performed its molecular and functional characterization, revealing that PiZ<sub>marseille</sub> shares the pathogenic properties of both the PiZ and PiZ<sub>bristol</sub> variants. These properties include its retention in the endoplasmic reticulum as aggregates and its degradation through the autophagy and proteasome pathways. Additionally, we conducted proteomic profiling to explore the association of this mutant with liver disease. Our analysis revealed that the neutrophil degranulation pathway is particularly deregulated in PiZ<sub>marseille</sub> liver samples. Furthermore, when compared to other AAT genotypes, the proteomic profile of PiZ<sub>marseille</sub> most closely resembles that of the PiZ variant, rather than other <i>SERPINA1</i> variants.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Characterization of a novel SERPINA1 variant carrying two missense mutations: molecular mechanisms and functional impact

  • Celine Leon,
  • Marie-Françoise Odou,
  • Bertrand Roquelaure,
  • Louis Lebreton,
  • Mathias Ruiz,
  • Carolin Victoria Schneider,
  • Celine Renoux,
  • Aurélie Evrard,
  • Malika Balduyck,
  • Magali Dechomet,
  • Christine Lombard,
  • Mathilde Butori-Pepino,
  • Kai Markus Schneider,
  • Victor Marin,
  • Sylvaine di-Tomasso,
  • Cyril Dourthe,
  • Jean-William Dupuy,
  • Anne-Aurélie Raymond,
  • Sophie Collardeau-Frachon,
  • Aurélie Haffner,
  • Radia Fritih,
  • Emmanuelle Goubert,
  • Vanna Geromel,
  • Philippe Joly,
  • Alexandre Fabre,
  • Marion Bouchecareilh

摘要

Alpha 1-Antitrypsin Deficiency (AATD) is a rare genetic disorder caused by mutations in the SERPINA1 gene, which encodes the Alpha 1-Antitrypsin (AAT) protein. Individuals carrying pathogenic SERPINA1 variants are predisposed to lung and liver damage. The most common AATD-associated SERPINA1 alleles are the S and Z alleles, though additional variants have been identified. This study describes the discovery of a new SERPINA1 variant detected in two unrelated families from two cities in southeastern France. This variant, named PiZmarseille, results from in cis combination of the PiZ allele and a rare variant known as PiZbristol. PiZmarseille has been associated with early-onset liver disease in childhood. To further investigate this new variant, we performed its molecular and functional characterization, revealing that PiZmarseille shares the pathogenic properties of both the PiZ and PiZbristol variants. These properties include its retention in the endoplasmic reticulum as aggregates and its degradation through the autophagy and proteasome pathways. Additionally, we conducted proteomic profiling to explore the association of this mutant with liver disease. Our analysis revealed that the neutrophil degranulation pathway is particularly deregulated in PiZmarseille liver samples. Furthermore, when compared to other AAT genotypes, the proteomic profile of PiZmarseille most closely resembles that of the PiZ variant, rather than other SERPINA1 variants.